Angiotech Pharmaceuticals and Boston Scientific Corporation's paclitaxel-eluting coronary stent system [Taxus Express2] has been approved in Japan

Source: Inpharma, Volume 1, Numbers 1582-1583, 2007-04-07 , pp. 23-23(1)

Publisher: Adis International

Keywords: Angiotech-Pharmaceuticals; Boston-Scientific-Corporation; Coronary-artery-restenosis, prevention; Coronary-stenting; Development-status; Drug-eluting-stents; Paclitaxel, therapeutic use; Product-approvals

Document Type: Short communication

Publication date: 2007-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers